J&J gets $116M to help hustle along new Ebola vaccine

January 16, 2015 3:39 PM

12 0

Just days after Johnson & Johnson ($JNJ) began a Phase I study of its new Ebola vaccine the pharma giant has organized an alliance to help accelerate its work and picked up a $116 million-plus grant to add to its $200 million commitment to get the job done as quickly as possible.

J&J sub Janssen has signed up a research consortium that now includes the London School of Hygiene & Tropical Medicine, University of Oxford, Institut National de la Sante et de la Recherche Medicale, La Centre Muraz, Bavarian Nordic A/S, Vibalogics, Grameen Foundation and World Vision of Ireland. T...

Read more

To category page